About Us
News
Products
Technolongy Platform
Investors
Contact Us
中文
EN
NEWS
Business Milestones
Patents
ALL
無列表圖
Business Milestones
06.13
2025
TAHO Pharmaceuticals to Showcase Cardiovascular Innovations at BIO International Convention 2025
無列表圖
Business Milestones
06.11
2025
TAHO Pharmaceuticals Receives Patent Acceptance for TAH3311 Apixaban Oral Dissolving Film in South Africa
無列表圖
Business Milestones
05.19
2025
TAHO Pharmaceuticals Secures Singapore Patent for TAH3311 Apixaban Anticoagulant Oral Dissolving Film
無列表圖
Business Milestones
05.09
2025
TAHO Pharmaceuticals’ TAH3311, The First and Only Anticoagulant Oral Film, Achieves Pivotal Study Success
無列表圖
Business Milestones
04.02
2025
TAHO Pharmaceuticals Receives Patent Grant from the New Zealand Patent Office for TAH3311 Apixaban Anticoagulant Oral Dissolving Film
無列表圖
Business Milestones
03.11
2025
TAHO Pharmaceuticals to Present Cardiovascular Innovations at BIO Europe Spring 2025
無列表圖
Business Milestones
02.17
2025
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
無列表圖
Business Milestones
01.21
2025
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
無列表圖
Business Milestones
11.17
2024
TAHO Pharmaceuticals Initiates U.S. Pivotal Trial of TAH3311 Antithrombotic Oral Dissolving Film, Dosing First Subjects
無列表圖
Patents
04.21
2021
TAHO's TAH9922 Atomoxetine oral solution product patent obtained a US patent license.
1
2
Next Page
Last Page
中文
EN
About Us
News
Products
Technolongy Platform
Investors
Contact Us
ADD
3F., No. 550, Ruiguang Road, Neihu District, Taipei, 11492, Taiwan
TEL
+886-2-2659-8515
MAIL
info@tahopharma.com
© 2023 TAHO Pharmaceuticals Ltd. All rights reserved.
Design ibest
Verification
Click the numbers in sequence.
Change
